Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
Naloxone Hydrochloride (UNII: F850569PQR) (Naloxone - UNII:36B82AMQ7N)
Dr. Reddys Laboratories, Inc.
INTRAMUSCULAR
PRESCRIPTION DRUG
Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. Naloxone hydrochloride is also indicated for diagnosis of suspected or known acute opioid overdosage. Naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see CLINICAL PHARMACOLOGY; Adjunctive Use in Septic Shock ). Naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients in naloxone hydrochloride. Naloxone hydrochloride is an opioid antagonist. Physical dependence associated with the use of naloxone hydrochloride has not been reported. Tolerance to the opioid antagonist effect of naloxone hydrochloride is not known to occur
Naloxone hydrochloride injection USP, for intravenous, intramuscular, and subcutaneous administration is available as: 1 mg/mL Each carton contains one 2 mg/2 mL Single-Dose Luer-Lock Prefilled Syringe and a 21 G x 1 ½” safety needle. NDC 43598-750-11 (contains no preservative) Ten cartons containing 2 mL Single-Dose Prefilled Syringe are packaged in an outer shipping box. NDC 43598-750-58 (contains no preservative). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light. Store in carton until contents have been used. Distributor: Dr. Reddy's Laboratories, Inc. Princeton, NJ 08540 Made in India
Abbreviated New Drug Application
NALOXONE HYDROCHLORIDE- NALOXONE HYDROCHLORIDE INJECTION DR. REDDY’S LABORATORIES, INC. ---------- Naloxone Hydrochloride Injection, USP _OPIOID ANTAGONIST_ Rx Only --------------------------------------- DESCRIPTION Naloxone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone. In structure it differs from oxymorphone in that the methyl group on the nitrogen atom is replaced by an allyl group. NALOXONE HYDROCHLORIDE (-)-17-Allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride Naloxone hydrochloride dihydrate occurs as a white to almost white powder, and is freely soluble in water, soluble in ethanol (96%); practically insoluble in toluene. Naloxone hydrochloride injection, USP is available as a sterile solution for intravenous, intramuscular and subcutaneous administration in 1 mg/mL concentration. pH is adjusted to 3.5 ± 0.5 with hydrochloric acid. Each mL also contains 9 mg of sodium chloride. Naloxone hydrochloride injection, USP is preservative-free. CLINICAL PHARMACOLOGY COMPLETE OR PARTIAL REVERSAL OF OPIOID DEPRESSION Naloxone hydrochloride prevents or reverses the effects of opioids including respiratory depression, sedation, and hypotension. Also, naloxone hydrochloride can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Naloxone hydrochloride is an essentially pure opioid antagonist, i.e., it does not possess the “agonistic” or morphine-like properties characteristic of other opioid antagonists. When administered in usual doses and in the absence of opioids or agonistic effects of other opioid antagonists, it exhibits essentially no pharmacologic activity. Naloxone hydrochloride has not been shown to produce tolerance or cause physical or psychological dependence. In the presence of physical dependence on opioids, naloxone hydrochloride will produce withdrawal symptoms. However, in the presence of opioid dependence, opiate withdrawal symptoms may appear within minutes of naloxone hydrochloride administration and subside Les hele dokumentet